Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-098557
Filing Date
2011-11-14
Accepted
2011-11-14 16:41:24
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q c24020e10vq.htm 10-Q 222634
2 EXHIBIT 31.1 c24020exv31w1.htm EX-31.1 9633
3 EXHIBIT 31.2 c24020exv31w2.htm EX-31.2 9583
4 EXHIBIT 32.1 c24020exv32w1.htm EX-32.1 4368
  Complete submission text file 0000950123-11-098557.txt   1200000

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT athx-20110930.xml EX-101.INS 119816
6 EX-101 SCHEMA DOCUMENT athx-20110930.xsd EX-101.SCH 9125
7 EX-101 CALCULATION LINKBASE DOCUMENT athx-20110930_cal.xml EX-101.CAL 27566
8 EX-101 LABELS LINKBASE DOCUMENT athx-20110930_lab.xml EX-101.LAB 93651
9 EX-101 PRESENTATION LINKBASE DOCUMENT athx-20110930_pre.xml EX-101.PRE 59491
Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 216-431-9900
ATHERSYS, INC / NEW (Filer) CIK: 0001368148 (see all company filings)

EIN.: 204864095 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33876 | Film No.: 111203449
SIC: 2834 Pharmaceutical Preparations